Literature DB >> 19280644

NMP-modified PMMA bone cement with adapted mechanical and hardening properties for the use in cancellous bone augmentation.

Andreas Boger1, Kurtis Wheeler, Andrea Montali, Elliot Gruskin.   

Abstract

The use of polymethylmethacrylate (PMMA) to reinforce vertebral bodies (Vertebroplasty) leads to an increase in the Young's modulus of the augmented vertebral body. Fractures in the adjacent vertebrae may be the consequence thereof. Hence, PMMA with a reduced Young's modulus may be suitable for vertebroplasty. The goal of this study was to produce and characterize stiffness-adapted PMMA cements. Modified PMMA bone cements were produced by adding N-methyl-pyrrolidone (NMP). Young's modulus, yield strength, polymerization temperature, setting time, and hardening behavior of different cements were analyzed. Focus was on the mechanical properties of the material after different storage conditions (in air at room temperature and in PBS at 37 degrees C). The Young's modulus decreased from 2670 MPa (air)/2384 MPa (PBS) for the regular cement to 76 MPa (air)/320 MPa (PBS) for a material composition with 60% of the MMA substituted by NMP. Yield strength decreased from 85 MPa (air)/78 MPa (PBS) to 2 MPa (air)/24 MPa (PBS) between the regular cement and the 60% composition. Polymerization temperature decreased from 70 degrees C (regular cement) to 48 degrees C for the 30% composition. The hardening behavior exhibited an extension in handling time up to 200% by the modification presented. Modification of PMMA cement using NMP seems to be a promising method to make the PMMA cement more compliant for the use in cancellous bone augmentation in osteoporotic patients: adjustment of its mechanical properties close to those of cancellous bone, lower polymerization temperature, and extended handling time.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19280644     DOI: 10.1002/jbm.b.31345

Source DB:  PubMed          Journal:  J Biomed Mater Res B Appl Biomater        ISSN: 1552-4973            Impact factor:   3.368


  7 in total

1.  The effect of standard and low-modulus cement augmentation on the stiffness, strength, and endplate pressure distribution in vertebroplasty.

Authors:  Michael Kinzl; Lorin M Benneker; Andreas Boger; Philippe K Zysset; Dieter H Pahr
Journal:  Eur Spine J       Date:  2011-12-15       Impact factor: 3.134

2.  Vertebroplasty and Kyphoplasty Can Restore Normal Spine Mechanics following Osteoporotic Vertebral Fracture.

Authors:  Jin Luo; Michael A Adams; Patricia Dolan
Journal:  J Osteoporos       Date:  2010-06-20

3.  The effect of oligo(trimethylene carbonate) addition on the stiffness of acrylic bone cement.

Authors:  Cecilia Persson; Alejandro López; Hoda Fathali; Andreas Hoess; Ramiro Rojas; Marjam Karlsson Ott; Jöns Hilborn; Håkan Engqvist
Journal:  Biomatter       Date:  2016

4.  Clinical outcome comparison of polymethylmethacrylate bone cement with and without mineralized collagen modification for osteoporotic vertebral compression fractures.

Authors:  Xi Wang; Jian-Ming Kou; Yang Yue; Xi-Sheng Weng; Zhi-Ye Qiu; Xi-Feng Zhang
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

5.  Functional Properties of Low-Modulus PMMA Bone Cements Containing Linoleic Acid.

Authors:  Céline Robo; David Wenner; S J Kumari A Ubhayasekera; Jöns Hilborn; Caroline Öhman-Mägi; Cecilia Persson
Journal:  J Funct Biomater       Date:  2021-01-17

6.  Radiofrequency-targeted vertebral augmentation versus traditional balloon kyphoplasty: radiographic and morphologic outcomes of an ex vivo biomechanical pilot study.

Authors:  Brian E Dalton; Andrew C Kohm; Larry E Miller; Jon E Block; Robert D Poser
Journal:  Clin Interv Aging       Date:  2012-11-19       Impact factor: 4.458

7.  Experimental investigations of the aerated polymethylmethacrylate-based vertebral cement flow in capillaries.

Authors:  Zbigniew Tyfa; Dariusz Witkowski; Krzysztof Sobczak; Damian Obidowski; Krzysztof Jóźwik
Journal:  Int J Artif Organs       Date:  2018-07-18       Impact factor: 1.595

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.